- Tekmira Pharmaceuticals (TKMR -0.1%) Q2 results: Revenues: $1.8M (-35.7%); Operating Expenses: $11.1M (+94.7%); Net Loss: ($6.1M) (-103.3%); Loss Per Share: ($0.28) (-33.3%); Quick Assets: $129.5M.
- No financial guidance given.
Tekmira reports Q2 results
Recommended For You
About ABUS Stock
Related Stocks
| Symbol | Last Price | % Chg |
|---|---|---|
| ABUS | - | - |
| Arbutus Biopharma Corporation | ||